GMAB:NASDAQ
Genmab A/S - ADR
$32.70
arrow_upward
+0.15%(+0.050) 1D
Sep 15, 9:52:40 AM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GMAB...
Open
$32.34
High
$32.71
Low
$32.34
Mkt. cap
20.52B
Avg. vol.
2.45M
Volume
135.46K
P/E ratio
25.77
52-wk high
$35.43
52-wk low
$23.62
EPS
$1.27
Beta
0.84
Shares outstanding
624.06M
No. of employees
3K
Open
$32.34
High
$32.71
Low
$32.34
Mkt. cap
20.52B
Avg. vol.
2.45M
Volume
135.46K
P/E ratio
25.77
52-wk high
$35.43
52-wk low
$23.62
EPS
$1.27
Beta
0.84
Shares outstanding
624.06M
No. of employees
3K
News stories
From web sources and news partners
Investing.com
·
27 minutes ago
Genmab at Morgan Stanley conference: pipeline widens, data loom
ad-hoc-news.de
·
19 hours ago
Genmab stock gains support as HC Wainwright reiterates buy rating and $40 target
Investing.com
·
1 day ago
H.C. Wainwright reiterates Genmab stock rating at buy, $40 target
GuruFocus
·
1 day ago
GMAB Reiterates by HC Wainwright & Co. -- Price Target Maintained at $40
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab A/S - ADR
CEOJan G. J. van de Winkel
Employees3.12K
Founded1999
Headquarters-
SectorBiotechnology
Websitegenmab.com